Page last updated: 2024-10-30

metformin and Leukemia, Lymphoblastic, Acute, T Cell

metformin has been researched along with Leukemia, Lymphoblastic, Acute, T Cell in 2 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vara-Ciruelos, D1
Dandapani, M1
Russell, FM1
Grzes, KM1
Atrih, A1
Foretz, M1
Viollet, B1
Lamont, DJ1
Cantrell, DA1
Hardie, DG1
Grimaldi, C1
Chiarini, F1
Tabellini, G1
Ricci, F1
Tazzari, PL1
Battistelli, M1
Falcieri, E1
Bortul, R1
Melchionda, F1
Iacobucci, I1
Pagliaro, P1
Martinelli, G1
Pession, A1
Barata, JT1
McCubrey, JA1
Martelli, AM1

Other Studies

2 other studies available for metformin and Leukemia, Lymphoblastic, Acute, T Cell

ArticleYear
Phenformin, But Not Metformin, Delays Development of T Cell Acute Lymphoblastic Leukemia/Lymphoma via Cell-Autonomous AMPK Activation.
    Cell reports, 2019, 04-16, Volume: 27, Issue:3

    Topics: Administration, Oral; AMP-Activated Protein Kinases; Animals; Cell Proliferation; Disease Models, An

2019
AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications.
    Leukemia, 2012, Volume: 26, Issue:1

    Topics: Adenylate Kinase; Apoptosis; Base Sequence; Cell Line, Tumor; DNA Primers; Flow Cytometry; Humans; M

2012